Role of simulation-based training and assessment to improve brachytherapy competency among radiation oncology residents
Simulation is a technique used in healthcare to replicate clinical scenarios and improve patient safety, efficacy, and efficiency. Simulation-based medical education facilitates training and assessment in healthcare without increasing risk to patients, supported by ample evidence from surgical/procedural specialties. Simulation in radiation oncology has been leveraged to an extent, with successful examples of both screen-based and hands-on simulators that have improved confidence and performance in trainees. (Source: Brachytherapy)
Source: Brachytherapy - April 19, 2024 Category: Cancer & Oncology Authors: Ria Mulherkar, Chirag Shah, Mitchell Bulat, Nikhil G. Thaker, Mitchell Kamrava, Sushil Beriwal Tags: Review Article Source Type: research
Radiotherapy induced ureteric stenosis in locally advanced cervical cancer: A review of current evidence
Concurrent chemo-radiation followed by high dose rate brachytherapy is the standard of care for locally advanced cervical cancer. The proximity of the ureters to the tumor volume risks ureteric stenosis. Here we outline the current understanding of radiotherapy induced ureteric stenosis in patients treated for cervical cancer, focusing on the incidence, risk factors, clinical consequences, and management. (Source: Brachytherapy)
Source: Brachytherapy - April 19, 2024 Category: Cancer & Oncology Authors: Asma Sarwar, Gemma Eminowicz Tags: Review article Source Type: research
Dosimetric and toxicity comparison between Syed-Neblett and Fletcher-Suit-Delclos Tandem and Ovoid applicators in high dose rate cervix cancer brachytherapy
To compare patient and tumor characteristics, dosimetry, and toxicities between interstitial Syed-Neblett and intracavitary Fletcher-Suit-Delclos Tandem and Ovoid (T&O) applicators in high dose rate (HDR) cervical cancer brachytherapy. (Source: Brachytherapy)
Source: Brachytherapy - April 19, 2024 Category: Cancer & Oncology Authors: Andres Portocarrero-Bonifaz, Salman Syed, Maxwell Kassel, Grant W. McKenzie, Vishwa M. Shah, Bryce M. Forry, Jeremy T. Gaskins, Keith T. Sowards, Thulasi Babitha Avula, Adrianna Masters, Scott R. Silva Tags: Original Article Source Type: research
Clinical outcomes of adaptive intracavitary and interstitial brachytherapy technique in locally advanced cervical cancer: A real-world data
To evaluate clinical outcomes of CT-based adaptive intracavitary and interstitial brachytherapy (IC followed by IC-ISBT) in locally advanced cervical cancer (LACC) in resource-constrained settings. (Source: Brachytherapy)
Source: Brachytherapy - April 18, 2024 Category: Cancer & Oncology Authors: Sheetal R Kashid, Lavanya Gurram, Saritha Pullan, Supriya Chopra, Prachi Mittal, Yogesh Ghadi, A Dheera, Libin Scaria, Satish Kohle, Sudarshan Kadam, Jaya Ghosh, Sushmita Rath, Sudeep Gupta, Umesh Mahantshetty Source Type: research
Exclusive Ru-106 brachytherapy for the management of a recurrent corneo: Conjunctival squamous cell carcinoma
We report a case of personalized exclusive brachytherapy treatment for the management of a highly recurrent squamous cell conjunctival carcinoma with corneal invasion. (Source: Brachytherapy)
Source: Brachytherapy - March 30, 2024 Category: Cancer & Oncology Authors: Matteo Mario Carl à, Maria Grazia Sammarco, Federico Giannuzzi, Gustavo Savino, Maria Antonietta Blasi, Bruno Fionda, Luca Tagliaferri, Monica Maria Pagliara Tags: Case Report Source Type: research
Explainable artificial intelligence analysis of brachytherapy boost receipt in cervical cancer during the COVID-19 era
Brachytherapy is a critical component of the standard-of-care curative radiotherapy regimen for women with locally advanced cervical cancer (LACC). However, existing literature suggests that many patients will not receive the brachytherapy boost. We used machine learning (ML) and explainable artificial intelligence to characterize this disparity. (Source: Brachytherapy)
Source: Brachytherapy - March 28, 2024 Category: Cancer & Oncology Authors: Colton Ladbury, Nicholas Eustace, Ari Kassardjian, Arya Amini, Yi-Jen Chen, Edward Wang, Adrian Kohut, Ana Tergas, Ernest Han, Mihae Song, Scott Glaser Tags: Review Article Source Type: research
Net survival of men with localized prostate cancer after LDR brachytherapy
To compare survival of patients who received LDR prostate brachytherapy relative to that of peers in the general population of England, UK. (Source: Brachytherapy)
Source: Brachytherapy - March 26, 2024 Category: Cancer & Oncology Authors: Santiago Uribe-Lewis, Jennifer Uribe, Claire Deering, Suzanne Langley, Donna Higgins, Danielle Whiting, Mohamed Metawe, Sara Khaksar, Sheel Mehta, Christos Mikropoulos, Sophie Otter, Carla Perna, Stephen Langley Tags: Original Article Source Type: research
Prospective validation of a machine learning model for applicator and hybrid interstitial needle selection in high-dose-rate (HDR) cervical brachytherapy
To Demonstrate the clinical validation of a machine learning (ML) model for applicator and interstitial needle prediction in gynecologic brachytherapy through a prospective clinical study in a single institution. (Source: Brachytherapy)
Source: Brachytherapy - March 26, 2024 Category: Cancer & Oncology Authors: Kailyn Stenhouse, Michael Roumeliotis, Philip Ciunkiewicz, Kevin Martell, Sarah Quirk, Robyn Banerjee, Corinne Doll, Tien Phan, Svetlana Yanushkevich, Philip McGeachy Tags: Original Article Source Type: research
Hypofractionated whole breast IMRT with HDR brachytherapy boost in early-stage breast cancer: Long-term results from a single-center
The addition of a boost to the lumpectomy bed after whole-breast (WB) radiotherapy plays a key role in the treatment of patients with breast cancer (BC). The clinical benefits of a boost with high-dose-rate brachytherapy (HDR-BT) after conventional fractionation is supported by a large body of evidence. However, few studies have described its outcomes after a hypofractionated scheme. (Source: Brachytherapy)
Source: Brachytherapy - March 23, 2024 Category: Cancer & Oncology Authors: Ana Aurora D íaz-Gavela, Elia del Cerro Peñalver, Sofía Sanchez-Garcia, Eduardo Pardo-Perez, Israel John Thuissard-Vasallo, Cristina Andreu-Vázquez, María Yolanda Molina López, Marina Pena Huertas, Luis Leonardo Guerrero-Gómez, David Sanz-Rosa, Fel Tags: Original Research Source Type: research
Corrigendum to “BLEEDERS IN CHECK: A Duke RadOnc Approach to Limiting Interruptions in GYN HDR Brachytherapy Treatments” [Brachytherapy September-October 2023; 22(5 Suppl):S90]
The authors regret that there was an error in our author block. We missed to provide the new married name of one of our authors, Amber Byrd. Some professional titles were also omitted. Author details were missed during our proofreading. Otherwise, there is no correction to abstract content. (Source: Brachytherapy)
Source: Brachytherapy - March 21, 2024 Category: Cancer & Oncology Authors: Rustica Blasco Cerillo, Amber W. Byrd, Mary Ann Monson, Lisa Thigpen, Kimberly DeBaun Tags: Corrigendum Source Type: research
Can an in-person hands-on applicator-based teaching session improve trainee knowledge and comfort with complex gynecologic brachytherapy?
With the emergence of imaged-based planning and hybrid applicators the complexity of gynecologic brachytherapy has dramatically increased. Despite the known advantages of brachytherapy, notable national declines in utilization of brachytherapy have been documented. Clearly improved education in the sphere of gynecologic brachytherapy is needed. We hypothesize that a hands-on applicator-based training session would improve trainee comfort with gynecologic brachytherapy. (Source: Brachytherapy)
Source: Brachytherapy - March 21, 2024 Category: Cancer & Oncology Authors: Abigail Groszkiewicz, Emily Foust, Brett Palestra, Michelle C. Ertel, Michelle Boisen, Paniti Sukumvanich, Shannon Kroskie Smith, Ryan P. Smith, John A. Vargo Source Type: research
A randomized trial evaluating a novel hydrogel packing system compared to standard packing during image-guided high-dose rate brachytherapy boost for cervical cancer
The purpose of this prospective randomized trial was to compare the use of a novel vaginal hydrogel packing system (BrachyGel) to standard vaginal packing (VP) during high dose rate (HDR) brachytherapy (BT) for locally advanced cervical cancer (LACC). (Source: Brachytherapy)
Source: Brachytherapy - March 21, 2024 Category: Cancer & Oncology Authors: Kara D. Romano, Gina Petroni, Kristi Ward, Wendy Zheng, Matthew Mistro, Bruce Libby, Christopher McLaughlin, Timothy N. Showalter, Einsley M. Janowski Tags: Original Article Source Type: research
21 Gy single fraction prostate HDR brachytherapy: 5-year results of a single institution prospective pilot study
To present the outcome and toxicity results of a prospective trial of 21 Gy single fraction high-dose-rate (HDR) brachytherapy for men with low- or intermediate-risk prostate cancer. (Source: Brachytherapy)
Source: Brachytherapy - March 20, 2024 Category: Cancer & Oncology Authors: Kamran Salari, Allison J. Hazy, Hong Ye, Evelyn Sebastian, Amy Limbacher, Matthew Johnson, Beth Mitchell, Andrew B. Thompson, Zachary A. Seymour, Sirisha R. Nandalur, Daniel J. Krauss Source Type: research
Brachytherapy for favorable prognostic prostate cancer in men up to 60 years of age: Long term follow-up
Brachytherapy (BT) is a standard treatment for low- and favorable intermediate-risk prostate adenocarcinoma. Few studies have focused on young patients. We therefore evaluated long-term efficacy and toxicity of BT in patients aged ≤ 60 years with low- and favorable intermediate-risk prostate cancer. (Source: Brachytherapy)
Source: Brachytherapy - March 12, 2024 Category: Cancer & Oncology Authors: Juliette Jacques, Nassim Sahki, Émilie Meknaci, Pascal Eschwege, Didier Peiffert, Nicolas Demogeot Tags: Original Article Source Type: research
Effects of pain management using nonsteroidal anti-inflammatory drug suppositories during brachytherapy for cervical cancer: A single-center prospective observational study
This study aimed to investigate the effects of pain management during intracavitary brachytherapy using nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen suppositories. (Source: Brachytherapy)
Source: Brachytherapy - March 9, 2024 Category: Cancer & Oncology Authors: Yuko Matsuda, Yusuke Nagamine, Tomoya Irie, Takahisa Goto Tags: Original Article Source Type: research
